milrinone has been researched along with Tachypnea in 2 studies
Tachypnea: Increased RESPIRATORY RATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A four- and a half-month-old girl with severe dilated cardiomyopathy due to neonatal enterovirus myocarditis, treated with diuretics and milrinone for the past 4 months, was infected with SARS-CoV-2." | 4.02 | SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy. ( Knudsen, PK; Kristoffersen, AW; Møller, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kristoffersen, AW | 1 |
| Knudsen, PK | 1 |
| Møller, T | 1 |
| Perez, M | 1 |
| Kumar, TK | 1 |
| Figueroa, M | 1 |
| Johnson, J | 1 |
| Absi, MA | 1 |
2 other studies available for milrinone and Tachypnea
| Article | Year |
|---|---|
SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; COVID-19; Diarrhea; Diuretics; Echocardiography; Entero | 2021 |
Case 2: Acute-onset tachypnea, tachycardia, and reduced activity in a 16-month-old girl.
Topics: Acute Disease; Antibodies, Viral; Cardiotonic Agents; Coxsackievirus Infections; Diagnosis, Differen | 2015 |